Author:
Blumenthal Deborah T.,Gorlia Thierry,Gilbert Mark R.,Kim Michelle M.,Burt Nabors L.,Mason Warren P.,Hegi Monika E.,Zhang Peixin,Golfinopoulos Vassilis,Perry James R.,Hyun Nam Do,Erridge Sara C.,Corn Benjamin W.,Mirimanoff René O,Brown Paul D.,Baumert Brigitta G.,Mehta Minesh P.,van den Bent Martin J.,Reardon David A.,Weller Michael,Stupp Roger
Publisher
Oxford University Press (OUP)
Subject
Cancer Research,Clinical Neurology,Oncology
Reference36 articles.
1. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma;European Organisation for Research and Treatment of Cancer Brain Tumor and Radiotherapy Groups; National Cancer Institute of Canada Clinical Trials Group;N Engl J Med,2005
2. Central nervous system cancers, version 1.2015;J Natl Compr Canc Netw,2015
3. Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre, randomised, open-label, phase 3 trial;European Organisation for Research and Treatment of Cancer (EORTC); Canadian Brain Tumor Consortium; CENTRIC study team;Lancet Oncol,2014
4. A randomized trial of bevacizumab for newly diagnosed glioblastoma;N Engl J Med,2014
5. Two cilengitide regimens in combination with standard treatment for patients with newly diagnosed glioblastoma and unmethylated MGMT gene promoter: results of the open-label, controlled, randomized phase II CORE study;Neuro Oncol,2015
Cited by
112 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献